Progesterone and progestins: Effects on brain, allopregnanolone and β-endorphin

Journal of Steroid Biochemistry and Molecular Biology

Volumn 102, Issue 1-5 SPEC. ISS., 2006, Pages 205-213

  Pluchino, N ^a   Luisi, M ^a   Lenzi, E ^a   Centofanti, M ^a   Begliuomini, S ^a   Freschi, L ^a   Ninni, F ^a   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Allopregnanolone; Beta endorphin; Brain; Progesterone; Progestins

Indexed keywords

ANIMALS; BETA-ENDORPHIN; BRAIN; HUMANS; PREGNANOLONE; PROGESTERONE; PROGESTINS;

EID: 33750973921     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.09.023     Document Type: Article

References (93)

1. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8 (2005) 3-63
2. Nilsen J., and Brinton R.D. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc. Natl. Acad. Sci. 100 (2003) 10506-10511
3. Simoncini T., Mannella P., Fornari L., Caruso A., Willis M.Y., Garibaldi S., Baldacci C., and Genazzani A.R. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145 (2004) 5745-5756
4. Tsai M.-J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63 (1994) 451-486
5. Guichon-Mantel A., Loosefelt H., Lescop P., et al. Mechanisms of nuclear localization of the progesterone receptor evidence for interaction between monomers. Cell 57 (1989) 1147-1154
6. Weigel N.L. Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 3 (1996) 657-667
7. Horwitz K.B., Jackson T.A., Blain D.L., Richer J.K., Takimoto G.S., and Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10 (1996) 1167-1177
8. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
9. Conneely O.M., Kettelberger D.M., Tsai M.-J., Schrader W.T., and O'Malley B.W. The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem. 264 (1989) 14062-14064
10. Giangrande P.H., and McDonnell D.P. The A and B isoforms of the human progesterone receptor two functionally different transcription factors encoded by a single gene. Recent Prog. Horm. Res. 54 (1999) 291-313
11. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., and Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289 (2000) 1751-1754
12. Conneely O.M., Mulac-Jeecevic B., and Lydon J.P. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone isoforms. Steroids 68 (2003) 771-778
13. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., Miller W.T., and Edwards D.P. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8 (2001) 269-280
14. Lena C., and Changeux J.P. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16 (1993) 181-186
15. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 9949-9953
16. Denner L.A., Weigel N.L., Maxwell B.L., Schrader W.T., and O'Malley B.W. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743
17. Wang M.D., Wahlström G., and Bäckström T. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J. Steroid Biochem. Mol. Biol. 62 (1997) 299-306
18. Stoffel-Wagner B., Watzka M., Schramm J., Bidlingmaier F., and Klingmuller D. Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J. Steroid Biochem. Mol. Biol. 70 (1999) 237-241
19. Baulieu E.E. Neurosteroids: a new function in the brain. Biol. Cell 71 (1991) 3-10
20. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52 (1997) 1-32
21. Wolf O.T., Neumenm O., and Helhammer D.H. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82 (1997) 2363-2367
22. Schumacher M., Coirini H., and McEwen B.S. Regulation of high affinity GABAA receptors in the dorsal hippocampus by estradiol and progesteron. Brain Res. 487 (1989) 178-184
23. Palumbo M.A., Salvestroni C., Gallo R., Guo A.L., Genazzani A.D., Artini P.G., Petraglia F., and Genazzani A.R. Allopregnanolone concentrations in hippocampus of prepubertal rats and female rats throughout estrous cycle. J. Endocrinol. Invest. 18 (1995) 853-856
24. Genazzani A.R., Bernardi F., Stomati M., Monteleone P., Luisi S., Rubino S., Farzati A., Casarosa E., Luisi M., and Petraglia F. Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Neuroendocrinology 72 (2000) 162-170
25. Genazzani A.R., Palumbo M.A., de Micheroux A.A., Artini P.G., Criscuolo M., Ficarra G., Guo A.L., Benelli A., Bertolini A., and Petraglia F. Evidence for a role for the neurosteroid allopregnanolone in the modifications of reproductive function in female rats. Eur. J. Endocrinol. 133 (1995) 375-380
26. Stomati M., Bernardi F., Luisi S., Puccetti S., Casarosa E., Liut M., Quirici B., Pieri M., Genazzani A.D., Luisi M., and Genazzani A.R. Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas 43 (2002) 195-206
27. Genazzani A.R., Stomati M., Bernardi F., Luisi S., Casarosa E., Puccetti S., Genazzani A.D., Palumbo M., and Luisi M. Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil. Steril. 81 (2004) 757-766
28. Bitran D., Purdy R.H., and Kellogg C.K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol. Biochem. Behav. 45 (1993) 423-428
29. Bitran D., Shiekh M., and McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroendocrinol. 7 (1995) 171-177
30. Frye C.A., Bayon L.E., Pursnani N.K., and Purdy R.H. The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res. 808 (1998) 72-83
31. Corpechot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., Mouren M., Prasad V.V., Banner C., Sjovall J., et al. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993) 1003-1009
32. Bernardi F., Pluchino N., Pieri M., Begliuomini S., Lenzi E., Puccetti S., Casarosa E., Luisi M., and Genazzani A.R. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology 24 (2006)
33. A.R. Genazzani, N. Pluchino, S. Begliuomini, M. Pieri, M. Centofanti, L. Freschi, E. Casarosa, M. Luisi, Drospirenone increases central and peripheral β-endorphin in ovariectomized female rats, Menopause, 2006, in press.
34. Rabe T., Kowald A., Ortmann J., and Rehberger-Schneider S. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro. Gynecol. Endocrinol. 14 (2000) 223-230
35. Plotsky P.M., Cunningham Jr. E.T., and Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev. 10 (1989) 437-458 (Review)
36. B. Bohus, J.M. Koolhas, S.M. Korte, Psychological stress, anxiety and depression: psychological and neuroendocrine correlates in animal model, In: A.R. Genazzani, G. Nappi, F. Petraglia, E. Martignoni (Eds.), Stress and related disorders from adaptation to dysfunction, Parthenon publishing group, Carnforth, UK, pp. 59-73.
37. Etgen A.M., and Karkanias G.B. Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology. 19 (1994) 603-610
38. Genazzani A.R., Petraglia F., and Purdy R.H. The Brain: Source Target for Sex Steroid Hormones (1996), Parthenon publishing group, Carnforth, UK
39. Panay N., and Studd J.W. The psychotherapeutic effects of estrogens. Gynecol. Endocrinol. 12 (1998) 353-365
40. Biegon A., Bercovitz H., and Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res. 187 (1980) 221-225
41. Luine V.N., and McEwen B.S. Effect of oestradiol on turnover of type A monoamine oxidase in brain. J. Neurochem. 28 (1977) 1221-1227
42. Dickinson S.L., and Curzon G. 5-Hydroxytryptamine-mediated behaviour in male and female rats. Neuropharmacology 25 (1986) 771-776
43. Ladisich W. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinology 2 (1977) 257-266
44. Luine V.N., Khylchevskaya R.I., and McEwen B.S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 86 (1975) 293-306
45. Holzbauer M., and Youdim M.B. The oestrous cycle and monoamine oxidase activity. Br. J. Pharmacol. 48 (1973) 600-608
46. Genazzani A.R., Stomati M., Morittu A., Bernardi F., Monteleone P., Casarosa E., Gallo R., Salvestroni C., and Luisi M. Progesterone, progestagens and the central nervous system. Hum. Reprod. 15 Suppl 1 (2000) 14-27 (Review)
47. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., and Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003) 3-29
48. Thomas, Nockels R.P., Pan H.Q., Shaffrey C.I., and Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24 (1999) 2134-2138
49. Gonzalez Deniselle Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., and Denicola A.F. Progesterone neuroprotection in the wobbler mouse, a genetic model of spinal cord motor disease. Neurobiol. Dis. 11 (2002) 457-468
50. Yu W.H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 491 (1989) 379-382
51. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 24 (2001) 386-391
52. Roof R.L., Duvdevani R., Heyburn J.W., and Stein D.G. Progesterone rapidly decreases brain edema: treatment delayed up to 24 h is still effective. Exp. Neurol. 138 (1996) 246-251
53. Roof R.L., Duvdevani R., Braswell L., and Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129 (1994) 64-69
54. Yu W.H. Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res. 491 (1989) 379-382
55. Thomas A.J., Nockels R.P., Pan H.Q., Shaffrey C.I., and Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24 (1999) 2134-2138
56. Jiang N., Chopp M., Stein D.G., and Feldblum S. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 735 (1996) 101-107
57. Peters A. Structural changes in the normally aging cerebral cortex of primates. Prog. Brain Res. 136 (2002) 455-465
58. Ghoumari A.M., Ibanez C., el-Etr M., Leclerc P., Eychenne B., Baulieu E.E., and Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86 (2003) 848-859
59. Labrie F., Lagacè L., and Drouin J. Direct and differential effects of sex steroids at the anterior pituitary level on LH and FSH secretion. In: Klopper A., Lerner A.B., van der Molen H.J., and Sciarra J.J. (Eds). Research on Steroids vol. 8 (1979), Academic Press, London 207
60. Etgen A.M., and Karkanias G.B. Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychonbeuroendocrinology 19 (1994) 603-610
61. Genazzani A.R., Petraglia F., Facchinetti F., et al. Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am. J. Obstet. Gynecol. 149 (1984) 775-779
62. Genazzani A.R., Petraglia F., Facchinetti F., et al. Steroid replacement increase beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. Gynecol. Obstet. Invest. 26 (1988) 153-159
63. Aleem F.A., and McIntosh T. Menopausal syndrome: plasma levels of beta-endorphin in postmenopausal women using a specific radioimmunoassay. Maturitas 13 (1985) 76-84
64. Piva F., Limonta P., Dondi D., Pimpinelli F., et al. Effects of steroids on the brain opioid system. J. Steroid Biochem. Mol. Biol. 53 (1995) 343-348
65. Wardlaw S.L., Wehrenberg W.B., Ferin M., Antunes J.L., and Frantz A.G. Effect of sex steroids on beta-endorphin in hypophyseal portal blood. J. Clin. Endocrinol. Metab. 55 (1982) 877-881
66. Fox S.R., Harlan R.E., Shivers B.D., and Pfaff D.W. Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology 51 (1990) 276-283
67. Dufourny L., Caraty A., Clarke I.J., Robinson J.E., and Skinner D.C. Progesterone-receptive beta-endorphin and dynorphin B neurons in the arcuate nucleus project to regions of high gonadotropin-releasing hormone neuron density in the ovine preoptic area. Neuroendocrinology 81 (2005) 139-149
68. Genazzani A.R., Petraglia F., Bergamaschi M., Genazzani A.D., Facchinetti F., and Volpe A. Progesterone and progestins modulate β-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. Gynecol. Endocrinol. 81 (1987) 61-69
69. Szot P., Wilkinson C.W., White S.S., Leverenz J.B., Greenup J.L., Colasurdo E.A., Peskind E.R., and Raskind M.A. Chronic cortisol suppresses pituitary and hypothalamic peptide message expression in pigtailed macaques. Neuroscience 126 (2004) 241-246
70. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11 (1988) 308-314
71. Hammarback S., Backstrom T., Holst J., von Schoultz B., and Lyrenas S. Cyclical changes as in premenstrual tension syndrome during sequential estro-progestin postmenopausal replacement therapy. Acta. Obstet. Gynecol. Scan. 64 (1985) 393-397
72. Genazzani A.R., Petraglia F., Mercuri N., Brilli G., Genazzani A.D., Bergamaschi M., De Ramundo B.M., and Volpe A. Effects of steroid hormones and antihormones on hypothalamic β-endorphin concentrations in intact and castrated female rats. J. Endocrinol. Invest. 64 (1990) 91-96
73. Magos A.L., Brewster E., Sing R., O'Dowd T.M., and Studd J.W. The effect of norethisterone in postmenopausal women on estrogen therapy: a model for premenstrual syndrome. Br. J. Obstet. Gynecol. 93 (1998) 1290-1296
74. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72 (1991) 336-343
75. Holst J., Backstrom T., Hammerbsck S., and von Schoultz B. Progestogen addition during estrogen replacement therapy-effects opn vasomotor symptoms and mood. Maturitas 11 (1989) 13-19
76. Freeman E.W., Purdy R.H., Coutifaris C., Rickels K., and Paul S.M. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58 (1993) 478-484
77. De Wit H., Schmitt L., Purdy R., and Hauger R. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26 (2001) 697-710
78. Bernardi F., Pieri M., Stomati M., Luisi S., Palumbo M., Pluchino N., Ceccarelli C., and Genazzani A.R. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol. Endocrinol. 17 (2003) 65-77
79. Soderpalm A.H., Lindsey S., Purdy R.H., Hauger R., and Wit de H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29 (2004) 339-354
80. Pluchino N., Genazzani A.D., Bernardi F., Casarosa E., Pieri M., Palumbo M., Picciarelli G., Gabbanini M., Luisi M., and Genazzani A.R. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol. Endocrinol. 20 (2005) 144-149
81. Miczek K.A., Fish E.W., and De Bold J.F. Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm. Behav. 44 (2003) 242-257
82. Beauchamp M.H., Ormerod B.K., Jhamandas K., Boegman R.J., and Beninger R.J. Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol. Biochem. Behav. 67 (2000) 29-35
83. Wieland S., Lan N.C., Mirasedeghi S., and Gee K.W. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one. Brain Res. 565 (1991) 263-268
84. Bjorn I., Bixo M., Nojd K.S., Collberg P., Nyberg S., Sundstrom-Poromaa I., and Backstrom T. The impact of different doses of MPA on mood symptoms in sequential hormonal therapy. Gynecol. Endocrinol. 16 (2002) 1-8
85. Andreen L., Bixo M., Nyberg S., Sundstrom-Poromaa I., and Backstrom T. Progesterone effects during sequential hormone replacement therapy. Eur. J. Endocrinol. 48 (2003) 571-577
86. Andreen L., Sundstrom-Poromaa I., Bixo M., Andersson A., Nyberg S., and Backstrom T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 30 (2005) 212-224
87. Dennerstein L., Burrows G.D., Hyman G., and Sharpe K. Hormone therapy and affect. Maturitas 1 (1979) 247-254
88. Genazzani A.R., Lucchesi A., Stomati M., Catarsi S., Genazzani A.D., Criscuolo M., and Petraglia F. Effects of sex steroid hormones on the neuroendocrine system. Eur. J. Contracep. Reprod. Health Care 2 (1997) 63-69
89. Comitini G., Petraglia F., Facchinetti F., and Genazzani A.R. Effect of oral contraceptives or dexamethasone on plasma beta-endorphin during the menstrual cycle. Fertil. Steril. 51 (1989) 46-50
90. Genazzani A.R., Petraglia F., Facchinetti F., et al. Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am. J. Obstet. Gynecol. 149 (1984) 775-779
91. Linghtman S.L., Jacobs H.S., Maguire A.K., et al. Climateric flushing: clinical and endocrine response to infusion of naloxone. Br. J. Obstet. Gynecol. 88 (1981) 919-924
92. Sherwin B., and Gelfand M.M. A prospective one-year study of estrogen and progestin in postmenopausal women; effects on clinical symptoms and lipoprotein lipids. Obstet. Gynecol. 73 (1989) 759-766
93. Stomati M., Bersi C., Rubino S., Palumbo M., Comitini G., Genazzani A.D., Petraglia F., and Genazzani A.R. Neuroendocrine effects of different oestradiol-progestin regimens in postmenopausal women. Maturitas 29 (1998) 271